Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anne Busquet currently holds 26,250 shares of MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anne Busquet has been a net seller of MTBC stock. They have purchased $211.5K and sold $771.5K worth of shares.
Anne Busquet's most recent insider trade was on Feb 8, 2026, when they sold 7,500 shares at $0.00 per share.
Anne Busquet serves as Executive at MEDICAL TRANSCRIPTION BILLING, CORP (MTBC). They have executed 66 insider transactions totaling $982.9K over their tenure at the company.
Anne Busquet holds the position of Executive at MEDICAL TRANSCRIPTION BILLING, CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Anne Busquet has shown a selling trading pattern, with $211.5K in total purchases and $771.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anne Busquet was on Mar 4, 2021, when they sold $436.5K worth of MTBC shares. This transaction involved 50,000 shares at $8.73 per share.
Anne Busquet currently owns 26,250 shares of MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anne Busquet's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anne Busquet has 66 Form 4 filings on record as an insider at MEDICAL TRANSCRIPTION BILLING, CORP.
Set alerts for Anne Busquet and 40,000+ other insiders.